5 Biotechs Awaiting FDA Decisions in January 2018 Post author:Sam Post published:December 27, 2017 Post category:BioPharma From 1997 through 2013, there was an average of 27 novel drugs approved in the U.S. per year. Source: BioSpace You Might Also Like PhaseRx Reports First Quarter 2017 Financial Results and Provides Corporate Update May 11, 2017 Bay Area's Gritstone Oncology to Ramp Up Hiring at New Manufacturing Facility November 27, 2017 Astellas, Vical's Lead CMV Vaccine Flunks Key Phase III Study January 21, 2018